Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer

doi:10.3748/wjg.v20.i21.6691

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 21

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6703)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

361

WORD

183

HTML

3911

Figures (1-4)

207

Sum=4662

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1191

Download

850

Sum=2041

Jun 7, 2014 (publication date) through Nov 2, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jun 7, 2014; 20(21): 6691-6697
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6691

Full Size Figure Download Figure

Figure 1 Brain enhanced computed tomography scan of case 1 (8 h after coma). A mild degree of cerebral atrophy; no remarkable intracranial metastases were found.

Citation: Wang W, Zhao LR, Lin XQ, Feng F. Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer. World J Gastroenterol 2014; 20(21): 6691-6697
URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6691.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6691